Why the study?
The role of E2F transcription factor 1 (E2F1) and its downstream genes in human cardiac fibroblast differentiation during cardiac fibrosis remained to be determined.
Does silencing E2F1 or CCNE2 prevent TGF-β1-induced human cardiac fibroblast differentiation?
Does silencing E2F1 or CCNE2 prevent TGF-β1-induced human cardiac fibroblast differentiation?
E2F1 and its direct target CCNE2 play a vital role in TGF-β1-induced human cardiac fibroblast differentiation, highlighting a potential therapeutic target for cardiac fibrosis.
May support E2F1/CCNE2 as antifibrotic targets; hypothesis-generating and leaves open in vivo translation.
The differentiation of cardiac fibroblast to myofibroblast is the key process of cardiac fibrosis. In the study, we aimed to determine the function of E2F Transcription Factor 1 (E2F1) in human cardiac fibroblasts (HCFs) differentiation, search for its downstream genes and elucidate the function of them in HCFs differentiation. As a result, we found that E2F1 was up-regulated in TGF-β1-induced HCFs differentiation. Silencing the expression of E2F1 by siRNA in HCFs, we found that the expression of differentiation-related genes (Collagen-1, α-Smooth muscle actin, and Fibronectin-1) was significantly suppressed, combining with proliferation and migration assay, we determined that HCFs differentiation was decreased. Luciferase report assay and immunoprecipitation proved that the oncogene CCNE2 was a direct target gene of E2F1, overexpression of CCNE2 was found in differentiated HCFs, silencing the expression of CCNE2 by siRNA decreased HCFs differentiation. Our research suggested that E2F1 and its downstream target gene CCNE2 play a vital role in TGF-β1-induced HCFs differentiation, thus E2F1 and CCNE2 may be a potential therapeutic target for cardiac fibrosis.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: